nach oben

Urolithiasis

Erschienen in:

14.06.2018 | Original Paper

Oxalate transport by the mouse intestine in vitro is not affected by chronic challenges to systemic acid–base homeostasis

verfasst von: Jonathan M. Whittamore, Marguerite Hatch

Erschienen in: Urolithiasis | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

In rats, we recently showed how a chronic metabolic acidosis simultaneously reduced urinary oxalate excretion and promoted oxalate secretion by the distal colon leading to the proposition that acid–base disturbances may trigger changes to renal and intestinal oxalate handling. The present study sought to reproduce and extend these observations using the mouse model, where the availability of targeted gene knockouts (KOs) would offer future opportunities to reveal some of the underlying transporters and mechanisms involved. Mice were provided with a sustained load of acid (NH₄Cl), base (NaHCO₃) or the carbonic anhydrase inhibitor acetazolamide (ATZ) for 7 days after which time the impacts on urinary oxalate excretion and its transport by the intestine were evaluated. Mice consuming NH₄Cl developed a metabolic acidosis but urinary oxalate was only reduced 46% and not statistically different from the control group, while provision of NaHCO₃ provoked a significant 2.6-fold increase in oxalate excretion. For mice receiving ATZ, the rate of urinary oxalate excretion did not change significantly. Critically, none of these treatments altered the fluxes of oxalate (or chloride) across the distal ileum, cecum or distal colon. Hence, we were unable to produce the same effects of a metabolic acidosis in mice that we had previously found in rats, failing to find any evidence of the ‘gut-kidney axis’ influencing oxalate handling in response to various acid–base challenges. Despite the potential advantages offered by KO mice, this model species is not suitable for exploring how acid–base status regulates oxalate handling between the kidney and intestine.

Hatch M, Freel RW (2008) The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis. Semin Nephrol 28(2):143–151. https://doi.org/10.1016/j.semnephrol.2008.01.007 CrossRefPubMedPubMedCentral

Whittamore JM, Hatch M (2017) The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man. Urolithiasis 45(1):89–108. https://doi.org/10.1007/s00240-016-0952-z CrossRefPubMed

Robijn S, Hoppe B, Vervaet BA, D’Haese PC, Verhulst A (2011) Hyperoxaluria: a gut-kidney axis? Kidney Int 80(11):1146–1158. https://doi.org/10.1038/ki.2011.287 CrossRefPubMed

Costello JF, Smith M, Stolarski C, Sadovnic MJ (1992) Extrarenal clearance of oxalate increases with progression of renal-failure in the rat. J Am Soc Nephrol 3(5):1098–1104PubMed

Hatch M, Freel RW, Vaziri ND (1994) Intestinal excretion of oxalate in chronic-renal-failure. J Am Soc Nephrol 5(6):1339–1343PubMed

Hatch M, Freel RW (2003) Angiotensin II involvement in adaptive enteric oxalate excretion in rats with chronic renal failure induced by hyperoxaluria. Urol Res 31(6):426–432. https://doi.org/10.1007/s00240-003-0367-5 CrossRefPubMed

Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW (2006) Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int 69(4):691–698. https://doi.org/10.1038/sj.ki.5000162 CrossRefPubMed

Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW (2011) Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Am J Physiol Gastrointest Liver Physiol 300(3):G461–G469. https://doi.org/10.1152/ajpgi.00434.2010 CrossRefPubMed

Hatch M, Freel RW (2013) A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion. Urolithiasis 41(5):379–384. https://doi.org/10.1007/s00240-013-0601-8 CrossRefPubMed

10.

Whittamore JM, Hatch M (2015) Chronic metabolic acidosis reduces urinary oxalate excretion and promotes intestinal oxalate secretion in the rat. Urolithiasis 43(6):489–499. https://doi.org/10.1007/s00240-015-0801-5 CrossRefPubMed

11.

Charney AN, Goldfarb DS, Dagher PC (1995) Metabolic disorders associated with gastrointestinal disease. In: Arieff AI, DeFronzo RA (eds) Fluid, electrolyte, and acid–base disorders, 2nd edn. Churchill Livingstone, New York, pp 813–836

12.

Gennari FJ, Weise WJ (2008) Acid–base disturbances in gastrointestinal disease. Clin J Am Soc Nephrol 3(6):1861–1868. https://doi.org/10.2215/cjn.02450508 CrossRefPubMed

13.

Charney AN, Feldman GM (1984) Systemic acid–base-disorders and intestinal electrolyte transport. Am J Physiol Gastrointest Liver Physiol 247(1):G1–G12CrossRef

14.

Charney AN, Dagher PC (1996) Acid–base effects on colonic electrolyte transport revisited. Gastroenterology 111(5):1358–1368. https://doi.org/10.1053/gast.1996.v111.agast961111358 CrossRefPubMed

15.

Charney AN, Egnor RW, Alexander-Chacko J, Cassai N, Sidhu GS (2002) Acid–base effects on intestinal Na⁺ absorption and vesicular trafficking. Am J Physiol Cell Physiol 283(3):C971–C979. https://doi.org/10.1152/ajpcell.00079.2002 CrossRefPubMed

16.

Charney AN, Egnor RW, Henner D, Rashid H, Cassai N, Sidhu GS (2004) Acid–base effects on intestinal Cl^– absorption and vesicular trafficking. Am J Physiol Cell Physiol 286(5):C1062–C1070. https://doi.org/10.1152/ajpcell.00454.2003 CrossRefPubMed

17.

Freel RW, Whittamore JM, Hatch M (2013) Transcellular oxalate and Cl^– absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate. Am J Physiol Gastrointest Liver Physiol 305(7):G520–G527. https://doi.org/10.1152/ajpgi.00167.2013 CrossRefPubMedPubMedCentral

18.

Freel RW, Hatch M, Green M, Soleimani M (2006) Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice. Am J Physiol Gastrointest Liver Physiol 290(4):G719–G728. https://doi.org/10.1152/ajpgi.00481.2005 CrossRefPubMed

19.

Jiang ZR, Asplin JR, Evan AP, Rajendran VM, Velazquez H, Nottoli TP, Binder HJ, Aronson PS (2006) Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 38(4):474–478. https://doi.org/10.1038/ng1762 CrossRefPubMed

20.

Whittamore JM, Frost SC, Hatch M (2015) Effects of acid–base variables and the role of carbonic anhydrase on oxalate secretion by the mouse intestine in vitro. Physiol Rep 3(2):e12282. https://doi.org/10.14814/phy2.12282 CrossRefPubMedPubMedCentral

21.

Hafner P, Grimaldi R, Capuano P, Capasso G, Wagner CA (2008) Pendrin in the mouse kidney is primarily regulated by Cl^– excretion but also by systemic metabolic acidosis. Am J Physiol Cell Physiol 295(6):C1658–C1667. https://doi.org/10.1152/ajpcell.00419.2008 CrossRefPubMed

22.

Alesutan I, Daryadel A, Mohebbi N, Pelzl L, Leibrock C, Voelkl J, Bourgeois S, Dossena S, Nofziger C, Paulmichl M, Wagner CA, Lang F (2011) Impact of bicarbonate, ammonium chloride, and acetazolamide on hepatic and renal SLC26A4 expression. Cell Physiol Biochem 28(3):553–558. https://doi.org/10.1159/000335114 CrossRefPubMed

23.

Green ML, Hatch M, Freel RW (2005) Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats. Am J Physiol Renal Physiol 289(3):F536–F543. https://doi.org/10.1152/ajprenal.00025.2005 CrossRefPubMed

24.

Whittamore JM, Hatch M (2017) Loss of the anion exchanger DRA (Slc26a3), or PAT1 (Slc26a6), alters sulfate transport by the distal ileum and overall sulfate homeostasis. Am J Physiol Gastrointest Liver Physiol 313(3):G166–G179. https://doi.org/10.1152/ajpgi.00079.2017 CrossRefPubMedPubMedCentral

25.

Nowik M, Kampik NB, Mihailova M, Eladari D, Wagner CA (2010) Induction of metabolic acidosis with ammonium chloride (NH₄Cl) in mice and rats—species differences and technical considerations. Cell Physiol Biochem 26(6):1059–1072. https://doi.org/10.1159/000323984 CrossRefPubMed

26.

Ribayamercado JD, Gershoff SN (1984) Effects of sugars and vitamin-b-6 deficiency on oxalate synthesis in rats. J Nutr 114(8):1447–1453CrossRef

27.

Bushinsky DA, Grynpas MD, Asplin JR (2001) Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 59(4):1415–1423. https://doi.org/10.1046/j.1523-1755.2001.0590041415.x CrossRefPubMed

28.

Iversen NK, Malte H, Baatrup E, Wang T (2012) The normal acid base status of mice. Respir Physiol Neurobiol 180(2–3):252–257. https://doi.org/10.1016/j.resp.2011.11.015 CrossRefPubMed

29.

Freel RW, Hatch M, Earnest DL, Goldner AM (1980) Oxalate transport across the isolated rat colon. A re-examination. Biochem Biophys Acta 600(3):838–843CrossRefPubMed

30.

Hatch M, Freel RW (2003) Renal and intestinal handling of oxalate following oxalate loading in rats. Am J Nephrol 23(1):18–26. https://doi.org/10.1159/000066300 CrossRefPubMed

31.

Singh AK, Sjoblom M, Zheng W, Krabbenhoft A, Riederer B, Rausch B, Manns MP, Soleimani M, Seidler U (2008) CFTR and its key role in in vivo resting and luminal acid-induced duodenal HCO₃ ^– secretion. Acta Physiol 193(4):357–365. https://doi.org/10.1111/j.1748-1716.2008.01854.x CrossRef

32.

Wagner JD, Kurtin P, Charney AN (1985) Effect of systemic acid–base-disorders on colonic intracellular ph and ion-transport. Am J Physiol Gastrointest Liver Physiol 249(1):G39–G47CrossRef

33.

Feldman GM (1989) Effect of chronic metabolic-acidosis on net electrolyte transport in rat colon. Am J Physiol Gastrointest Liver Physiol 256(6):G1036–G1040CrossRef

34.

Goldfarb DS, Sly WS, Waheed A, Charney AN (2000) Acid–base effects on electrolyte transport in CA II-deficient mouse colon. Am J Physiol Gastrointest Liver Physiol 278(3):G409–G415CrossRefPubMed

35.

Charney AN, Egnor RW, Steinbrecher KA, Cohen MB (2004) Effect of secretagogues and pH on intestinal transport in guanylin-deficient mice. Biochim Biophys Acta Gen Subj 1671(1–3):79–86. https://doi.org/10.1016/j.bbagen.2004.01.007 CrossRef

36.

Brion LP, Cammer W, Satlin LM, Suarez C, Zavilowitz BJ, Schuster VL (1997) Expression of carbonic anhydrase IV in carbonic anhydrase II-deficient mice. Am J Physiol Renal Physiol 273(2):F234–F245CrossRef

37.

Lien YHH, Lai LW (1998) Respiratory acidosis in carbonic anhydrase II-deficient mice. Am J Physiol Lung Cell Mol Physiol 274(2):L301–L304CrossRef

38.

Packer RK, Curry CA, Brown KM (1995) Urinary organic anion excretion in response to dietary acid and base loading. J Am Soc Nephrol 5(8):1624–1629PubMed

39.

Knight TF, Senekjian HO, Weinman EJ (1979) Effect of para-aminohippurate on renal transport of oxalate. Kidney Int 15(1):38–42. https://doi.org/10.1038/ki.1979.5 CrossRefPubMed

40.

Lemann J, Gray RW, Pleuss JA (1989) Potassium bicarbonate, but not sodium-bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy-men. Kidney Int 35(2):688–695. https://doi.org/10.1038/ki.1989.40 CrossRefPubMed

41.

Lemann J, Hornick LJ, Pleuss JA, Gray RW (1989) Oxalate is overestimated in alkaline urines collected during administration of bicarbonate with no specimen pH adjustment. Clin Chem 35(10):2107–2110PubMed

42.

Mazzachi BC, Teubner JK, Ryall RL (1984) Factors affecting measurement of urinary oxalate. Clin Chem 30(8):1339–1343PubMed

43.

Chalmers AH, Cowley DM, McWhinney BC (1985) Stability of ascorbate in urine—relevance to analyses for ascorbate and oxalate. Clin Chem 31(10):1703–1705PubMed

44.

Fuller NJ, Elia M (1988) Factors influencing the production of creatinine - implications for the determination and interpretation of urinary creatinine and creatine in man. Clin Chim Acta 175(3):199–210. https://doi.org/10.1016/0009-8981(88)90096-4 CrossRefPubMed

45.

Miki K, Sudo A (1998) Effect of urine pH, storage time, and temperature on stability of catecholamines, cortisol, and creatinine. Clin Chem 44(8):1759–1762PubMed

46.

Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80(3):1107–1213CrossRef

47.

Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal-function - new insights into old concepts. Clin Chem 38(10):1933–1953PubMed

48.

Hamm LL, Simon EE (1987) Roles and mechanisms of urinary buffer excretion. Am J Physiol Renal Physiol 253(4):F595–F605CrossRef

49.

Wamberg S, Hansen AC, Engel K, Kildeberg P (1978) Balance of net base in rat. 3. Effects of oral sodium-bicarbonate and sodium citrate loading. Biol Neonate 34(1–2):24–31CrossRefPubMed

50.

Oster JR, Stemmer CL, Perez GO, Vaamonde CA (1988) Comparison of the effects of sodium-bicarbonate versus sodium-citrate on renal acid excretion. Miner Electrol Metab 14(2–3):97–102

51.

Brown JC, Packer RK, Knepper MA (1989) Role of organic-anions in renal response to dietary acid and base loads. Am J Physiol Renal Physiol 257(2):F170–F176CrossRef

52.

Eladari D, Leviel F, Pezy F, Paillard M, Chambrey R (2002) Rat proximal NHE3 adapts to chronic acid–base disorders but not to chronic changes in dietary NaCl intake. Am J Physiol Renal Physiol 282(5):F835–F843. https://doi.org/10.1152/ajprenal.00188.2001 CrossRefPubMed

53.

Lemann J, Lennon EJ, Goodman AD, Litzow JR, Relman AS (1965) Net balance of acid in subjects given large loads of acid or alkali. J Clin Investig 44(4):507–517. https://doi.org/10.1172/jci105164 CrossRefPubMed

54.

Hood VL (1985) pH regulation of endogenous acid production in subjects with chronic ketoacidosis. Am J Physiol Renal Physiol 249(2):F220–F226CrossRef

55.

Lindinger MI, Franklin TW, Lands LC, Pedersen PK, Welsh DG, Heigenhauser GJF (2000) NaHCO₃ and KHCO₃ ingestion rapidly increases renal electrolyte excretion in humans. J Appl Physiol 88(2):540–550CrossRefPubMed

56.

Khanna A, Kurtzman NA (2006) Metabolic alkalosis. J Nephrol 19:S86–S96PubMed

57.

Maren TH (1967) Carbonic anhydrase—chemistry physiology and inhibition. Physiol Rev 47(4):595–781CrossRefPubMed

58.

Swenson ER, Maren TH (1978) Quantitative-analysis of CO₂ transport at rest and during maximal exercise. Respir Physiol 35(2):129–159. https://doi.org/10.1016/0034-5687(78)90018-x CrossRefPubMed

59.

Harrison HE, Harrison HC (1955) Inhibition of urine citrate excretion and the production of renal calcinosis in the rat by acetazolamide (Diamox) administration. J Clin Investig 34(11):1662–1670. https://doi.org/10.1172/jci103220 CrossRefPubMed

60.

Hamm LL (1990) Renal handling of citrate. Kidney Int 38(4):728–735. https://doi.org/10.1038/ki.1990.265 CrossRefPubMed

61.

Welch BJ, Graybeal D, Moe OW, Maalouf NM, Sakhaee K (2006) Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis 48(4):555–563. https://doi.org/10.1053/j.ajkd.2006.07.003 CrossRefPubMed

62.

Ohana E, Shcheynikov N, Moe OW, Muallem S (2013) SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis. J Am Soc Nephrol 24(10):1617–1626CrossRefPubMedPubMedCentral

63.

Maren TH (1977) Use of inhibitors in physiological studies of carbonic-anhydrase. Am J Physiol Renal Physiol 232(4):F291–F297CrossRef

64.

Matlaga BR, Shah OD, Assimos DG (2003) Drug-induced urinary calculi. Rev Urol 5(4):227–231PubMedPubMedCentral

65.

Daudon M, Jungers P (2004) Drug-induced renal calculi—epidemiology, prevention and management. Drugs 64(3):245–275. https://doi.org/10.2165/00003495-200464030-00003 CrossRefPubMed

66.

Boer P, Beutler JJ, Vanrijn HJM, Berckmans RJ, Koomans HA, Mees EJD (1990) Urinary oxalate excretion during intravenous-infusion of diuretics in man. Nephron 54(2):187–188. https://doi.org/10.1159/000185846 CrossRefPubMed

67.

Higashihara E, Nutahara K, Takeuchi T, Shoji N, Araie M, Aso Y (1991) Calcium-metabolism in acidotic patients induced by carbonic-anhydrase inhibitors—responses to citrate. J Urol 145(5):942–948CrossRefPubMed

68.

Parikh JR, Nolan RL (1994) Acetazolamide-induced nephrocalcinosis. Abdom Imaging 19(5):466–467. https://doi.org/10.1007/bf00206942 CrossRefPubMed

69.

Mirza N, Marson AG, Pirmohamed M (2009) Effect of topiramate on acid–base balance: extent, mechanism and effects. Br J Clin Pharmacol 68(5):655–661. https://doi.org/10.1111/j.1365-2125.2009.03521.x CrossRefPubMedPubMedCentral

70.

Kaplon DM, Penniston KL, Nakada SY (2011) Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate. Urology 77(2):295–298. https://doi.org/10.1016/j.urology.2010.06.048 CrossRefPubMed

Titel: Oxalate transport by the mouse intestine in vitro is not affected by chronic challenges to systemic acid–base homeostasis
verfasst von: Jonathan M. Whittamore
Marguerite Hatch
Publikationsdatum: 14.06.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Urolithiasis / Ausgabe 3/2019
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-018-1067-5

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Analyses of long non-coding RNA and mRNA profiling using RNA sequencing in calcium oxalate monohydrate-stimulated renal tubular epithelial cells

Correction to: Testing the dogma that total phospholipid fatty acid composition of blood plays a role in kidney stone pathogenesis, using a high–low risk human model: results from a pilot study

High prevalence of pediatric urinary tract stones in Xinjiang Uyghur

Editorial comment